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Abstract
Research on decision support applications in healthcare, such as those related
to diagnosis, prediction, treatment planning, etc., have seen enormously in-
creased interest recently. This development is thanks to the increase in data
availability as well as advances in artificial intelligence and machine learning
research. Highly promising research examples are published daily. However,
at the same time, there are some unrealistic expectations with regards to the
requirements for reliable development and objective validation that is needed
in healthcare settings. These expectations may lead to unmet schedules and
disappointments (or non-uptake) at the end-user side. It is the aim of this
tutorial to provide practical guidance on how to assess performance reliably
and efficiently and avoid common traps. Instead of giving a list of do’s and
don’t s, this tutorial tries to build a better understanding behind these do’s
and don’t s and presents both the most relevant performance evaluation crite-
ria as well as how to compute them. Along the way, we will indicate common
mistakes and provide references discussing various topics more in-depth.
Keywords: Machine learning, Artificial intelligence, Biomedicine, Life
Sciences, Performance Assessment, Decision Support
1. Introduction
Data-driven approaches for healthcare decision support, such as those
driven by Machine Learning (ML), have seen a surge in interest over re-
cent years, partly driven by the promising results that a ’reborn’ AI research
Preprint submitted to Elsevier September 1, 2020
ar
X
iv
:2
00
8.
13
69
0v
1 
 [c
s.L
G]
  3
1 A
ug
 20
20
branch has generated. As the name says, these approaches rely on the avail-
ability of data to extract knowledge and train algorithms. This is opposed to,
e.g., modeling approaches in which physiological, physics-based, mathemati-
cal, and other equations form the basis of algorithms, or, rule-based systems
in which reasoning processes are obtained by translating domain-experts’
knowledge into computer-based rules.
Focusing on data-driven systems, the data plays a role in several com-
ponents during the development and actual usage phases. First, we need
data to extract knowledge from, i.e., to develop and train algorithms so that
they learn-by-example the properties of the problem at hand and get bet-
ter at solving the problem by repeatedly providing example data. Second,
we need to monitor during the development phase how promising the algo-
rithms are and make choices, e.g., concerning optimisation of parameters or
choosing different ML-paradigms. Methods that don’t perform well at all
can be discarded, and ones that seem promising can be further optimised.
To assess how promising a specific method is, we need to examine how it
performs on data that was not used during training. Finally, to objectively
assess how well the final ’best’ system performs, we need to apply completely
new data to it that has not been used at all thusfar during the research and
development process.
Thus, there are at least three stakeholders that have the interest to get
as large part of the data pie as possible. 1) the algorithm developer, to
get as good method development as possible; 2) the validation assessment
responsible, who would help to steer the development process as good as
possible; and 3) the decision-maker who wants to have as accurate as possible
assessment of the merits of the system. Thus, we need to make a trade-off
and think about efficient usage of the precious data, and need to carefully
define what we truly mean with performance evaluation and what kind of
measures or yardsticks would be appropriate when.
It is the aim of this paper to provide practical guidance on how to assess
performance reliable and efficiently and avoid common traps. We concentrate
on the challenges when dealing with decision support in the health-domain,
based on experiences gained in over 25 years of experience in the field.
1.1. Decision Support in Healthcare settings
Decision support in healthcare can mean many things. Perhaps the most
common example is that of computer-based systems helping doctors to di-
agnose a disease based on, e.g., medical images. This is a classification task
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(diseased vs. healthy-case, or disease A vs. disease B). In this case, the users
are healthcare professionals (medical doctors or radiologists). Other com-
mon decision-making tasks include risk assessment (the risk of developing a
disease), predicting hospital resource needs, treatment outcome, helping to
plan interventions (surgery or treatment plans), monitor a patient state over
time to see if a treatment has success.
From a data science point of view, there are many paradigms that can con-
tribute to decision support tools. Typical approaches include classification
methods, regression methods, and more explorative clustering approaches.
In this paper, we concentrate primarily on classification and regression ap-
proaches as they are an essential part of most decision support systems in
practice. Clustering approaches are often more related to research itself, of-
ten involving visualisation, and accurately quantifying their ’performance’ in
terms of numbers is often of less relevance.
1.2. Acceptance Criteria for Decision Support in Healthcare
Next to performance per se, there are many other criteria that influ-
ence whether an algorithm will find successful uptake in healthcare practice.
Possible criteria to fulfill in order to have successful uptake of methods in
practice:
• performance (classification) accuracy,
• usability
• ease of integration in existing processes
• robustness (e.g., deal with missing and poor quality data)
• explainability (no black box)
• cost-effectiveness
In this paper, we concentrate especially on the performance measures,
due to its crucial role in, e.g., diagnostics, risk assessment and treatment
planning. However, the other criteria are crucial as well and would deserve
separate discussion in dedicated tutorials.
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2. Supervised classification
This section reviews the background on supervised classification from a
more formal viewpoint and introduces the notation. For clarity, we will focus
on classification problems, but the treatment of regression problems would
be very similar. For this tutorial, this section sets the scene by introducing
the Bayes classifier, exemplifies how the Bayes classifier is approximated,
illustrates how the Bayes classification rule depends on the prior probability
of classes, and informs about sampling issues when training discriminative
classifiers.
2.1. General framework and notation
A classification task is to assign an object (in health applications, usually
a person) described by a feature vector x = [x1, . . . , xd] (e.g., measured
blood pressure levels, total cholesterol, age, sex) to one of the c classes (e.g.,
cardiovascular disease in the future or not). The c classes are denoted simply
as 1, . . . , c. In machine learning, a classifier is represented by a function α that
takes as an input a feature vector and outputs the class. In more practical
terms, a classifier outputs c values representing each class, and the class of
the highest (or lowest) value is the one selected. In supervised learning, this
function α is constructed based on training data, which is given by pairs
(xi, yi), where xi is the feature vector of an object belonging to the class
yi ∈ {1, . . . , c}. We assume to have N such pairs, constituting the training
data {(xi, yi)|i = 1, . . . , N}.
2.2. Bayes classifier
The classification problem is statistical by nature: two objects having
equal feature vectors can belong to different classes. Therefore, it is not
possible to derive a classifier that works perfectly i.e., always classifies every
object correctly. For a specified classification problem, the task is to derive a
classifier that makes as few errors (misclassifications) as possible, among all
possible objects to be classified. This is known as the Bayes classifier. The
Bayes classifier is a theoretical construct useful to study the classification
problem, but it needs the complete and accurate the statistical characterisa-
tion of the problem. In practice, this characterisation is not known and the
classifier must be learned based from training data. However, nearly all the
practical classifiers approximate the Bayes classifier in some sense.
To build the Bayes classifier, we assume to know the
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1. prior probabilities P (1), . . . , P (c) of the classes and
2. the class conditional probability density functions (pdfs) p(x|1), . . . , p(x|c).
The prior probability P (j) defines what percentage of all objects belong to
the class j. The class conditional pdf p(x|j) defines the pdf of the feature
vectors belonging to j. Obviously,
∑c
j=1 P (j) = 1.
The Bayes classifier is defined as
αBayes(x) = arg max
j=1,...,c
P (j|x), (1)
where P (j|x) is the posterior probability of the class j being the correct class
for the object with the feature vector x. 1 In other words, the Bayes classifier
selects the most probable class when the observed feature vector is x.
The posterior probability P (j|x) is evaluated based on the Bayes rule,
i.e., P (j|x) = p(x|j)P (j)
p(x)
. However, p(x) is equal for all classes and it can be
dropped. The Bayes classifier can now be rewritten as
αBayes(x) = arg max
j=1,...,c
p(x|j)P (j), (2)
i.e., the Bayes classifier computes the product of the class conditional density
at x and the prior for class j.
By its definition the Bayes classifier minimizes the conditional error E(α(x)|x) =
1−P (α(x)|x) for all x. Because of this and basic properties of integrals, the
Bayes classifier minimizes the classification error
E(α) =
∫
x
E(α(x)|x)p(x)dx. (3)
In the above equation, it is important to note that the integration is over all
possible feature vectors, not just those in the training set. This is the gener-
alization error that we are interested in estimating in the coming sections.
The classification error E(αBayes) of the Bayes classifier is called the Bayes
error. It is the smallest possible classification error for a fixed classification
problem. As mentioned previously, the Bayes classifier is a theoretical con-
struct: in practice we never know the class conditional densities p(x|j) or
class priors P (j)
1The notation arg maxx f(x) means the value of the argument x that yields the maxi-
mum value for the function f . For example, if f(x) = −(x− 1)2, then arg maxx f(x) = 1
(and max f(x) = 0).
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We remark that the definition of the Bayes classifier does not require the
assumption that the class conditional pdfs are Gaussian distributed. The
class conditional pdfs can be any proper pdfs.
2.3. Bayes formula example (Cancer test)
It is important to understand the role of the prior probabilities when
designing classification rules or considering the strength of evidence. This
equals to the understanding the Bayes formula. We give here a brief example,
which is summarized from 2 and 3, but similar examples appear in various of
statistics text books.
The example is based on the following scenario:
• 1% of women at age forty who participate in routine screening have
breast cancer, i.e., P (Cancer+) = 0.01, and therefore 99% do not, i.e.,
P (Cancer−) = 0.99;
• 80% of mammograms detect breast cancer when it is there (and there-
fore 20% miss it), i.e. P (Test+|Cancer+) = 0.80,P (Test−|Cancer+) =
0.20;
• 9.6% of mammograms detect breast cancer when it is not there (and
therefore 90.4% correctly return a negative result), i.e., P (Test+|Cancer−) =
0.096,P (Test− |Cancer−) = 0.904 .
A woman in this age group had a positive mammography in a routine screen-
ing. What is the probability that she actually has a breast cancer?
The correct answer is 7.8%, which can be quite counter-intuitive at the
first sight. The answer is obtained based on the Bayes rule. First, note that
the question asks for the posterior probability of breast cancer given that the
test was positive P (Cancer + |Test+). This probability was not provided
above and it must be computed based on the Bayes rule:
P (Cancer+|Test+) = P (Test+ |Cancer+)P (Cancer+)
P (Test+)
=
0.80 · 0.01
0.10304
= 7.8%.
Note that
P (Test+) = P (Test+|Cancer+)P (Cancer+)+P (Test+|Cancer−)P (Cancer−).
2http://yudkowsky.net/rational/bayes
3https://betterexplained.com/articles/an-intuitive-and-short-explanation-of-bayes-theorem/
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2.4. Sampling issues
The training data may be sampled in two distinct ways and it is important
to make a distinction between these. In mixture (or random) sampling, the
training data is collected for all classes simultaneously conserving the class-
proportions occurring in real-life. In separate sampling, the training data for
each class is collected separately. For the classifier training, the difference of
these two sampling techniques is that for the mixed sampling we can estimate
the priors P (1), . . . , P (c) as
Pˆ (j) =
nj∑c
k=1 nk
, (4)
where nj is the number of samples from the class j. On the other hand,
the prior probabilities cannot be deduced based on the separate sampling.
Most sampling in biomedicine and life sciences is separate sampling whereas
most standard textbooks assume mixture sampling. A good overview of the
challenges caused by the separate sampling is [1].
2.5. Practical classifiers
This subsection briefly explains how to construct classifiers based on the
training data {(xi, yi)|i = 1, . . . , N}. We can approach this problem in sev-
eral ways. The conceptually simplest is via generative plug-in classifiers.
These approximate the prior probabilities P (j) and the class conditional den-
sities p(x|j) by estimates Pˆ (j), pˆ(x|j) found based on training data and sub-
stitute these estimates to the formula of the Bayes classifier. The estimates
for class conditional pdfs can be either parametric (e.g., Naive Gaussian
Bayes, Discriminant analysis) or non-parametric (Parzen densities, mixture
models). These classifiers are called generative because they build a prob-
abilistic model of the classification problem that can be used to generate
data.
As an example, we consider the Gaussian Naive Bayes (GNB) classifier
for a two class classification problem. Training data is {(xi, yi)|i = 1, . . . , n},
where each yi is either 1 or 2. For convenience, we define D1 = {i|yi = 1}
and D2 = {i|yi = 2}, the indexes of the training samples belonging to the
class 1 and class 2, respectively. Moreover, let n1 and n2 be the number of
samples in classes 0 and 1, so that n = n1 + n2. For GNB, we make the
assumptions that 1) data in each class is Gaussian distributed and 2) each
feature is independent from each other feature. Denote xi = [xi1, xi2, . . . , xid],
where d is the number of features. The classifier training consists of
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1. Computing the mean for each feature k = 1, . . . , d, and each class
j = 1, 2: mjk = (1/nj)
∑
i:yi=j
xik.
2. Computing the variance for each feature k = 1, . . . , d, and each class
j = 1, 2: sjk = (1/nj)
∑
i:yi=j
(xij −mjk)2.
3. Computing the estimates Pˆ (1) = n1/n and Pˆ (2) = n2/n.
After these computations, the class for a test sample z = [z1, z2, . . . , zd] can
be computed by computing two discriminant values:
fj = pˆ(x|j)Pˆ (j) = [
d∏
k=1
G(zk;mjk, sjk)]nj/n,
and picking the class producing the larger discriminant. The functionG(·;m, s)
denotes Gaussian probability density with the mean m and variance s, i.e.,
G(z;m, s) = 1√
2spi
e−(z−m)
2/2s.
Most of the modern learning algorithms construct discriminative classi-
fiers. These do not aim to construct a generative model for a classification
problem, but try to more or less directly find a a classification model that
minimizes the number of misclassifications in the training data (see [2] for a
more elaborate definition of a discriminative classifier). For example, classi-
fiers such as support vector machines, Random Forests, and neural networks
belong to this class of classification algorithms. During the learning process,
the classifier is defined by a set of parameter values w, i.e., the classifier is a
function α(x; w), where the parameter vector w is to be learned during the
training. The training is typically done by optimizing a cost function (or a
loss function) f that is somehow related to the desired optimality criterion.
To give a simple example, consider a two-class problem, where the classes
are 0 and 1. Then, a simple but widely used loss function is L2-loss defined
as
f(w) =
n∑
i=1
(yi − α(xi; w))2
This loss function approximates the number of misclassifications in the train-
ing set. The number of misclassifications cannot be used as a loss function
as it not continuous and thus intractable to optimize. Discriminative clas-
sifiers are powerful and often preferred over the generative ones. However,
their formulation poses two related problems in biomedical and life science
applications, where the sizes of training sets are typically small. First, it may
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not be clear which optimality criterion the loss function approximates and if
the loss function approximates the correct optimality criterion. Second, in
the case of separate sampling, it must be taken into account that the prior
probabilities might not be correct [1]. These two problems are not that severe
with generative classifiers.
3. Classifier performance estimates
The performance of classifiers can be measured in many ways. All these
ways are related to the number of times the classifier was ’correct’ or ’wrong’
when processing new inputs in real-life usage. However, different usage sce-
narios introduce different views on what we mean with ’correct’ or ’wrong’,
and hence we have a range of different performance measures.
Performance estimates can rarely be used directly as optimization criteria
for discriminative classifiers as they are not continuous nor differentiable and
thus cannot be efficiently optimized. However, as stated in Section 2.5, the
loss function should approximate the desired performance measure.
3.1. Simple error rates
The simplest way of assessing performance is by calculating the number
of errors, or, correct classifications, that are made on a given set of data. It
is clear that if the number of errors is large the performance is not good. The
accuracy can be defined as a simple ratio:
accuracy =
number of correct classifications
total number of samples to classify
. (5)
A high accuracy (close to 1, or, 100%) might indicate that we have a
useful classifier. However, this is not always certain, especially not if the
prevalences of the different groups (e.g. diseased vs. healthy cases) are
imbalanced. If, e.g., we have the situation where we have a test test of 1000
cases, with 1 case being a ’disease case’ and 999 are ’healthy cases’, then we
can make a simple classifier that always classifies any case as ’healthy case’.
It would have an impressive accuracy of 999/1000 = 99.9%, but be useless in
practice, since its ability to correctly detect actual disease cases (which we
call sensitivity) is zero. For this reason, we advance from the simple accuracy
measure to a more in-depth look to quantify how well disease (and healthy)
cases are classified separately.
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true class
classification
healthy disease
healthy
116 5
True Negatives False Positives
disease
12 23
False Negatives True Positives
Table 1: An example of confusion matrix
3.2. Confusion matrix
The confusion matrix is a useful tool for quantifying the performance of
a classifier on different classes. By convention the rows of the matrix contain
the ground truths and the columns the classification results. Matrix element
(i,j) reflects the number of cases that belong to class i, and were classified as
belonging to class j. An example is given in Table 1.
In this case we have a 2-class problem (class 1 = ’healthy’, class 2 = ’dis-
ease’), and accordingly have a 2x2 matrix. On the rows are the true classes,
’actual healthy’ and ’actual disease’, as ground truth (e.g., as observed from
a confirmed clinical endpoint/diagnosis), and in the columns are ’classified
healthy’ and ’classified disease’. We can see that there were 116+5= 121
healthy cases in the set; 116 of them were correctly classified as healthy (we
call these True Negatives (TN)), 5 erroneously as disease (false alarms) (False
Positives (FP)). Also, there were 12+23 = 35 disease cases, 23 of them got
correctly classified (True Positives (TP)) and 12 wrongly assessed as belong-
ing to the healthy group (False Negatives (FN)). A perfect classifier would
have all non-zero values on the diagonal, and zeroes everywhere else. We
can see that the classifier overall works quite ok, but especially the detection
of disease cases (12 out of 35 classified wrongly) is not so great. Exploring
the confusion matrix is thus highly useful to get understanding about what
kind of errors are being made on what classes. We can derive several simple
quantities from the matrix that succinctly capture its main properties.
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3.3. Classification rate, sensitivity,and specificity, FPV, PPV, precision and
recall and F1 score
Performance of classifiers can be quantified by the following measures,
see also Table 2. All of them have values in the interval [0, 1].
accuracy: this is the total of correctly classified cases divided by the
total number of cases in the test set as in Eq. (5). In our example it is 0.891.
sensitivity: is the number of disease cases (that are by convention called
class positive) that were correctly classified, divided by the total number of
disease cases, i.e., TP
TP+FN
. It thus quantifies how well the classifier is able
to detect disease cases from the disease population, and thus appropriately
raises an alarm. A low sensitivity implies that many disease cases are missed.
In our case the sensitivity is 0.657
specificity: is the number of healthy cases (that are by convention called
class negative) that were correctly classified as such, divided by the total
number of healthy cases, i.e., TN
TN+FP
. It thus quantifies how well the clas-
sifier is able to detect healthy cases from the healthy population, and thus
appropriately stays quiet. A low specificity implies that many healthy cases
are classified as disease case, and many false alarms are generated. In our
case the specificity is 0.959.
positive predictive value (PPV): is the number of cases that actually
have a disease divided by the number of cases that the classifier classifies as
having a disease, i.e., TP
TP+FP
. It thus is a probability-related measure that
indicates how probable it is that a case has a disease when the classifier has
a positive/disease class as output. Or, more popularly, how much one should
believe the classifier when it indicates that the person has a disease. In our
case it is 0.821.
negative predictive value (NPV): is the number of cases that actually
are healthy divided by the number of cases that the classifier classifies as
being healthy, i.e., TN
TN+FN
. It thus is a probability-related measure that
indicates how probable it is that a person is healthy when the classifier has a
negative/healthy class as output. Or, more popularly, how much one should
believe the classifier when it indicates that the person is healthy. In our case
it is 0.906.
Sensitivity and specificity are perhaps the most common measures in clin-
ical tests and wider healthcare contexts, when we talk about the performance
of (diagnostic) tests or patient monitoring settings. In a wider application
area, also the following measures are used.
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true class
classification
healthy disease
healthy 116 5 specificity =
116/(116 + 5)
disease 12 23 sensitivity =
23/(12 + 23)
NPV =
116/(116 + 12)
PPV =
23/(5 + 23)
accuracy =
(116+23)
(116+5+12+23)
Table 2: The confusion matrix of Table 1 extended with summary values.
Precision: is the number of cases that actually belong to class X divided
by the number of that the classifier classifies as belonging to class X. If we
have a two-class classification problem (like in our example), precision is
identical to positive prediction value.
Recall: is the number of cases belonging to class X that were correctly
classified as class X, divided by the total number of class X cases. In a two-
class setting it is identical to sensitivity. Precision and Recall can be applied
to more-than-two class problems, which explains their widespread use in,
e.g., reporting of performance of machine learning algorithms.
The F1-score is the harmonic mean of precision and recall:
F1 = 2 · Precision ·Recall
Precision+Recall
. (6)
If either the precision or the recall have small values, the overall F1 score
will be small. It thus provides a more sensitive measure than accuracy.
3.3.1. The effect of class prevalence on PPV and NPV
A word of caution regarding PPV and NPV: their use is common, partly
because of the intuitivity of the measure (if my classification algorithm says
I have a disease, how much should I believe it). However, it should be kept
in mind that PPV and NPV are not only dependent on the performance of
the classifier per se, but are also dependent on how many cases of different
classes are present in the datasets. This relates to the prevalences of different
classes, or prior probabilities, and the earlier example regarding the breast
12
true class
classification
healthy disease
healthy 95 5 specificity =
0.95
disease 5 15 sensitivity =
0.75
NPV = 0.95 PPV = 0.75 accuracy = 0.92
Table 3: A dataset with 100 healthy cases and 20 disease cases
true class
classification
healthy disease
healthy 95 5 specificity =
0.95
disease 20 60 sensitivity =
0.75
NPV = 0.83 PPV = 0.92 accuracy = 0.92
Table 4: A dataset with 100 healthy cases and 80 disease cases. Sensitivity and specificity
have remained the same, but NPV, and especially PPV have increased considerably.
cancer screening (where we ended up with a surprisingly low PPV of 7.8%)
It can be further illustrated with a simple example, see Table 3 and 4.
The NPV and PPV are influenced by the ratio of disease and healthy
cases that happen to be in the test set. If the number of disease cases is
high, then also the PPV tends to be high. This is intuitively understandable
(if a diseases prevalence is high, it is easier to believe the classifier when
it classifies a case as disease, then it would be when the disease would be
rarely occurring). Thus the PPV and NPV are influenced by both the clas-
sifier performance and the number of cases of different classes in the test
set. They should thus not be used to compare classifiers performances when
those performances have been derived from different datasets. Sensitivity
and specificity do not suffer from this problem.
Different prevalences can (and are likely) to occur when we deal with
datasets that have been collected at different centres, in different geopgraph-
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ical locations with different processes etc. Another, more technical reason
why prevalences may get affected is when training sets are artificially being
balanced when a certain class is underrepresented. Training a classifier on
a class that has only a few instances may be difficult, and one way to deal
with that is by repeating/copying the few rare disease cases in the set to
alleviate training. Thus we are artificially increasing prevalence, and, as a
consequence, PPV.
3.3.2. Dealing with more than two classes
The examples above relate to two-class problems, but in reality we often
have cases where we have more than two classes. For example, classifying
different patient states/disorders in an ICU, or in differential diagnostics. We
already saw that precision and recall naturally are defined for any number of
classes. Sensitivity and specificity can be generalized to fit to a multi-class
problem by grouping classes. In those cases a 2-class setting is generated by
classifying one class vs all other classes together.
3.4. Balanced classification rate
As we saw, the accuracy-measure does not give a good insight in the over-
all usefulness of a classifier. Sensitivity, specificity, PPV, and NPV provide
better insights. If one wants to summarise the performance in one single
number, the balanced accuracy can be used as alternative to the regular
accuracy. For a 2-class classifier, it can be calculated as the average of sensi-
tivity and specificity. For the general case it is the average of the proportion
of correct classified cases for each class individually. If the classes are bal-
anced, e.g., there are as many cases in the disease group as there are in the
healthy group, then the balanced and regular accuracy are equal. However,
in cases where the number of cases for the different classes are not the same
(which is very common in healthcare settings), balanced accuracy gives a
more appropriate estimation of overall accuracy.
3.5. ROC curves and AUC
In the two-class classification problem there is often a trade-off between
having a high sensitivity (detect all persons who have a disease) versus high
specificity (avoid false alarms, detect all persons who are healthy). Usually
the classification is done by having a classifier output evaluated and use a
threshold on it (or ’decision criterion’) to decide whether to assign the input
data to class 0 or class 1. The value of the threshold defines then what the
14
Figure 1: Example distributions of outputs of a classifier algorithm for a 2-class problem.
The eventual class assignment is done by using a decision threshold. Moving this value
affects how many classified cases are True Negatives (TN), True Positives (TP), False
Negatives (FN) and False Positives (FP), and thus, what the values for sensitivity and
specificity are.
values of sensitivity and specificity are. An illustration of the problem is
given in Figure 1.
If we move the threshold (criterion value in Fig. 1) to low values (and
classify all persons who have a classifier output higher than that low value as
having a disease), all persons with a disease would be detected (sensitivity
= 1). However, also many healthy persons would be classified as having a
disease (false alarms, specificity is low). The opposite is also true - a high
threshold leads to high specificity but low sensitivity. Selecting the best
threshold is thus a trade-off between sensitivity and specificity. The problem
can be visualized in the so-called ROC curves (Receiver Operating Charac-
teristic), which have been around since the WWII, but have been introduced
into the medical field since the 1970s. They are a plot of 1-specificity on the
x-axis vs sensitivity on the y-axis (in some research disciplines, these axes
labels are sometimes labelled as FPR (false positive rate) on the x-axis, and
TPR (true positive rate) on the y-axis). An example of an ROC plot is given
in Figure 2.
It can be see that any threshold value below 0.72 has a sensitivity < 0.6
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Figure 2: An example of an ROC curve. In this case that of a classifier (Monophasic
Linear Detector) that is trained to classify brain activity: monophasic EEG vs normal
EEG. The numbers along the curve are different thresholds/criterion values to make the
final classification. More information can be found in [3]
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and any value above 0.8 has a specificity < 0.6. It can e.g. be seen that at
certain places a relatively small increase in threshold (from 0.79 to 0.82) leads
to a big effect in specificity (drop from 0.78 to 0.4). This type of explorations
helps to make informed decisions on the threshold settings. The point (0,1)
would give the ideal classifier, with both sensitivity and specificity having a
value of 1. Points on the curve closest to (0,1) would be the best classifier,
but it has to be kept in mind that usually there is a preference for either
the sensitivity or specificity (or both) to be in a certain region (sometimes
called ’clinically useful region’), and either of them may be given relatively
more importance. Thus, the curve provides a tool to explore the merits of
different thresholds.
Another common use for the ROC curve is to calculate its area-under-
the-curve (AUC), and use that as performance measure for the classifier. It
is a number between 0 and 1, with a value of 1 indicating that the classifier
will classify a randomly presented case always correctly. A value of 0.5 in-
dicates the classifier is not better than random guessing (and traditionally
the diagonal is plotted in the figure as well, indicating a random classifier for
comparison). A useful classifier should have an AUC (significantly) higher
than 0.5. How high an AUC should be for it to be good enough is application-
dependent. For some situations an AUC of 0.7 might already be very good,
for others 0.95 might be still rather poor. And, in some cases a lower AUC
might be clinically acceptable if ,e.g., the sensitivity is high. AUC is conve-
nient because it provides one single number to describe overall performance,
and as such, can be used to compare different classifiers against each other.
However, it should be kept in mind that it says nothing about the clinical
usefulness. A good recent overview of the discussion can be found in [4]. In
there, it is also described how the ROC curve in fact can be derived from the
pdf of the classifier outputs for different classes.
3.5.1. ROC curves and practical utility
The ROC curve may give us a tool to find optimal threshold values in
theory: a point on the curve as close as possible to (0,1) (equal to 1-specificity
= 0, sensitivity = 1)). However, there are many trade-offs to make when
considering the balance between sensitivity and specificity. For example: the
relative costs associated with acting upon a classified disease (when it is a
false classification), or the costs associated with not acting in case the disease
is actually present. Or, the discomfort to a patient associated to a possible
intervention (or discomfort when the disease is not treated) etc. Differences
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in costs for false positives vs false negatives may give rise to reconsideration
of the position of the optimal threshold to choose. Additionally, prevalence of
the disease plays a role. A good practical discussion of the ROC in healthcare
settings can be found at 4
There are 3 approaches to find ’optimal’ thresholds (see also, 5)
• Calculate the point on the ROC curve that has minimum distance to
(0,1). This assumes that sensitivity and specificity are of equal impor-
tance. It is easy to implement in an algortihm: calculate the distance
for each point on the curve, and choose as optimal the threshold the
point with the smallest distance.
• The second approach uses the logic that the point on the ROC curve
that is at the largest vertical distance from the diagonal represents
the optimal threshold. Informally, this could be motivated by saying
that, since points on the diagonal represent a ’random classifier’, points
far away from this would represent better classifiers - the further the
better. If we consider for a given x-co-ordinate (1-specificity), the y-
co-ordinate of the points on the ROC curve the sensitivity, and at
the diagonal (1-specificity), then the vertical distance is sensitivity -
(1-specificity) = sensitivity + specificity. This is called the Youden
index, J. Optimizing this value thus gives a threshold with the best
combination of sensitivity and specificity (or a maximum ’balanced
accuracy’). Alternatively, it can be looked upon as maximisation of
the difference between sensitivity and false positive rate. Again, we
assume equal importance for both.
• Finally, estimating the optimal threshold based on costs (cost - min-
imisation) would deliver the value that can be expected to yield the
highest benefit in the real-world. This does not assume that sensitivity
and specificity are equally important. The issue is that the costs asso-
ciated to misclassifications are highly diverse and difficult to estimate
as they originate from external processes (e.g. treatment processes),
personal patient circumstances (co-morbidities, social interactions, oc-
cupation), or local considerations (e.g. costs of tests, reimbursement
policies). Costs are either direct or indirect and may be incurred at
4http://www.anaesthetist.com/mnm/stats/roc/Findex.htm
5http://www.medicalbiostatistics.com/ROCCurve.pdf
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different time scales. Thus, there is no easy recipe as there was in
the first two approaches, and the effort needs to be seen more as part
of wider cost-effectiveness and impact-effectiveness studies, which are
major disciplines by themselves. Intuitively, it can be understood that,
if the cost of missing a disease diagnosis is high, and intervention (even
not-needed intervention of a person who is in reality healthy) is safe
and cheap, then the best thresholds can be found at the right top-
area of the curve: high sensitivity and accepting a high number of
false positives. On the other hand, if an intervention carries high-risk
and we are not convinced by its effectiveness, the threshold will be in
the left bottom corner: we minimise harming non-diseased people, but
take missing diseased persons for granted. In many cases in healthcare
settings, sensitivity is prioritised over specificity when it comes to de-
tecting critical patient states. However, it is good to keep in mind that
false positives are a major burden, e.g., in critical care patient moni-
toring, leading to ’alarm fatigue’ and potentially enormous costs [5] -
minimising false alarms is a main objective in many medical equipment
R&D efforts. Another recent example can be found in the context of
antibody testing for Covid-19. A false positive result may wrongly sug-
gest that a person is ’safe’ and can interact more freely with others,
with potentially disastrous consequences.
3.6. Other performance measures for classifiers
It is worth mentioning several other performance measures that are com-
monly used.
• The Youden index (or Youden’s J statistic) is defined as [6]
J = sensitivity + specificity − 1. (7)
Expressed in this way, it is obviously equivalent with the balanced
classification rate (or, balanced accuracy). However, the Youden index
is often used as the maximum potential effectiveness of a biomarker:
Jmax = max
c
{sensitivity(c) + specificity(c)− 1}, (8)
where c is a cut-off point [7].
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• The Matthews correlation coefficient (MCC) is the correlation between
the observed and predicted classifications [8]
MCC =
TP × TN − FP × FN√
(TP + FP )(TP + FN)(TN + FP )(TN + FN)
. (9)
It takes values between −1 and 1.
• The Dice index [9] is widely used in the evaluation of image segmen-
tation algorithms as it effectively ignores the correct classification of
negative samples (the background region). The Dice index is defined
as 2TP
2TP+FP+FN
. It has close connections to Cohen’s Kappa [10] and it
is equivalent to Jaccard coefficient (sometimes termed Tanimoto coef-
ficient) [11].
3.7. Performance measures for regression problems
In this subsection, we will briefly outline the most important performance
measures when facing a regression task, that is, when the variable to be
predicted is real valued, instead of categorical.
The majority of machine learning algorithms for regression problems aim
to minimize the mean squared error (MSE):
MSE =
1
N
N∑
i=1
(yˆi − yi)2, (10)
where yi is the correct value for target i and yˆi is our prediction of it. It puts
more emphasis on bigger errors more than on smaller ones (which makes sense
in many real life applications, it treats positive and negative errors equally
(also acceptable in many cases), and the square-function is mathematically
convenient for many optimisation algorithms. A related measure is mean
absolute error (MAE):
MAE =
1
N
N∑
i=1
|yˆi − yi|, (11)
which is less ’punishing’ to large errors. MSE and MAE report the error in
the scale and quantity of the original variables, which makes them sometimes
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hard to interpret and application dependent. Easier to interpret alternatives
are (Pearson) correlation coefficient
r =
1
N
N∑
i=1
(yˆi − mˆ)(yi −m)
ssˆ
, (12)
wherem = (1/N)
∑N
i=1 yi is the mean of the target variables, mˆ = (1/N)
∑N
i=1 yˆi
is the mean of the predictions, and s =
√
(1/N)
∑N
i=1(yi −m)2, and sˆ =√
(1/N)
∑N
i=1(yˆi − mˆ)2, are the corresponding standard deviations. The cor-
relation coefficient takes values between −1 and 1 and values near or below
zero signal useless predictor while high values (near 1) signal very good pre-
dictors.
The coefficient of determination (sometimes termed normalized MSE) is
defined as
Q2 = 1− (1/N)
∑
i(yi − yˆi)2
(1/N)
∑N
i=1(yi −m)2
.
Note that in contrast to explanatory modeling, in predictive modeling, the
coefficient of determination can take negative values, and it is not equal to
correlation squared [12]. This is why the notation Q2 is recommended instead
of R2.
3.8. Accuracy of the performance measures
The above described performance measures (sensitivity, specificity, AUC
of ROC etc) all give certain values based on the specific data and algorithm
that have been used. How accurate such a value is as estimation of the
performance on the general population is an important question. It may be
intuitively be expected that a sensitivity of 0.9 as calculated from a dataset
with 10000 cases is more accurate than one from 10 cases. Also, how do we
compare classifiers, and test e.g., whether algorithm A is ’significantly better’
than algorithm B, based on the AUC?
To estimate the standard error in sensitivity and specificity, different ap-
proaches exist. They all relate to the calculation of the confidence interval
of the binomial proportion (see, e.g., 6). The simplest implementation is the
asymptotic approach, which holds if the number of samples is very large.
6https://en.wikipedia.org/wiki/Binomial_proportion_confidence_interval
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Other, more refined versions use the Wilson score interval or the Clopper-
Pearson interval.
The confidence interval for the AUC is not trivial to calculate as it requires
assumptions about the underlying distributions. Just calculating the mean
and standard deviation from a number of pooled AUC observations is not
appropriate as the distribution of the ROC is not inherently normal, and the
’samples’ (AUC observations) are not independent, since the underlying data
remains constant. An authoritive paper from 1982 by Hanley and McNeil
[13] gives estimations that are relatively conservative and based on assump-
tions of exponentialility underlying score distributions. An alternative is to
determine instead the maximum of the variance over all possible continuous
underlying distributions with the same expected value of the AUC, which
gives an unpractically loose estimation. Cortes and Mohri [14] present an
approach which is distribution-independent and thus wider applicable.
A convenient calculator for the confidence interval of various measures
can be found at the ”Diagnostic test evaluation calculator” webpage 7.
3.8.1. Sources of errors
There can be many reasons why the performance measures are not ’exact’.
The abovementioned confidence intervals are based on taking into account
natural random variation in the observations, but the variation in the ob-
servations can have many underlying reasons, and may not be random at
all.
Some reasons why we cannot assess performance measures exactly in-
clude:
• Lack of Gold Standards : in the above discussions we implied that we
knew to which class (0 or 1) a person belonged, and what the algo-
rithms ’correct’ answer was supposed to be. However, in many cases
the situation is not that clear-cut. A 100% final diagnosis for a form of
dementia might be available only once pathology research can be per-
formed once the patient has deceased. Thus, if we classify that person’s
data while she is alive there may be a change that the ’correct refer-
ence’ is not actually correct - influencing our performance estimates.
For many patient states (e.g., awareness, anesthesia, pain etc.) we have
scales that are not absolute but have been accepted as ’good enough’
7https://www.medcalc.org/calc/diagnostic_test.php
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for practical use. All classification estimates on such scales are thus
inherently fraught with some uncertainty margin due to the fact that
we simply do not know the exact right answer.
• Inter-expert variability : to develop and train algorithms data needs to
be labelled and assigned to classes. This is typically done by experts in
the field. In many of the more complex diagnostic there is room for in-
terpretation, expert A might come to a different diagnostic conclusion
than expert B (based on earlier experience, processes etc.). In that
case the question arises, should we develop a classifier that matches
expert A as good as possible, or expert B (or C)? Or take the average
of both? For many datasets the reference data labels have been created
by having the different experts discuss with each other and come to a
comprise labelling that all agree with. Another approach is to quan-
tify the agreement-level between the expert opinions and use that as
performance target for the classifier.
• Limited representativeness of the development and test data: if data
has been collected in one hospital only, and is being tested on com-
pletely independent data from the same hospital, it may be so that the
performance when applied to data from other hospitals is disappoint-
ing. Different settings have different practices, different patient popu-
lations (with perhaps different disease prevalences), different types of
equipment and different staff - this all may lead to drastic changes in
the performance measures. Thus, it is essential in many applications
to use multi-centre studies involving different hospitals from different
countries, to make sure that the performance assessment results are
as generally applicable as possible. This, obviously, is an expensive
endeavour and a major reason for why uptake of new technologies in
clinical practice is slow.
4. Classifier performance estimation in practice
In the previous section, we outlined various performance measures. In
this section, we describe means to compute the performance measures in
practice and discuss potential pitfalls that may arise. We will concentrate on
non-parametric estimation principles (validation, cross-validation, bootstrap)
that are equally applicable for all the performance measures introduced in
the previous section. Hence, for clarity, we will focus on the estimation of
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the classification error (or equally, accuracy (Eq. (5))), noting that in the
most cases, it can be replaced by any performance measure.
Many fields of biomedicine have published their own guidelines on how
to evaluate machine learning algorithms, for example, in radiology [15, 16,
17, 18], and practitioners should be aware of the field-specific guidelines [19].
The TRIPOD (Transparent Reporting of a multivariable prediction model for
Individual Prognosis Or Diagnosis) Statement includes a 22-item checklist,
which aims to improve the reporting of studies developing, validating, or
updating a prediction model [20].
At the same time, it needs to be understood that not all the performance
estimation tasks are equal: different validation principles may be adept if
evaluating the potential of new technology for use in biomedicine or a pro-
totype of a product for clinical use. We recommend reading [21], which
summarizes the validation aspects from a clinical viewpoint, making strong
points for the public availability of predictive algorithms in health-care.
4.1. Training error versus test error, holdout method
Two error types can be distinguished in machine learning: the training
error and the test error. The training error refers to the classification errors
for the training samples, i.e., how large portion of the training samples is
misclassified by the designed classifier. The more important error type is
the test error 8, which describes how large portion of all possible objects
is misclassified by the deployed algorithm/model. The theoretical Bayes
classifier, introduced in Section 2, aims to minimize the test error when the
class conditional probability densities and priors are known. However, these
densities and priors are never known in practice.
The training error is the frequency of error for the training data. The
training error is an overly optimistic estimate of the test error. For example,
the training error of the nearest neighbour-classifier is automatically zero.
Obviously, this is not true for the test error. The estimation of the test error
by the training error is termed the resubstitution method. Using the resub-
stitution method to estimate classification error is a severe methodological
mistake, sometimes called testing on the training data.
8Test error is sometimes termed generalization error. However, some authors make a
difference between the two terms. See, e.g., [22] for en exact definition of the generalization
error.
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A much better estimate for the test error is obtained by dividing the train-
ing data into two disjoint sets, termed training and test sets. The training
set is used for the training of the classifier and the test set is solely used to
estimate the test error. This method to estimate the true test error is called
the holdout method. If a natural division of the data into test and training
sets does not exist, the division needs to be artificially produced. This arti-
ficial division needs to be randomized; for example, it is not a good idea to
select all the examples of one class as the test set and others as the training
set. It is a good practice to make the division stratified, so that there are
equal proportions of classes in the training and test sets. Especially in the
neural network literature, one encounters divisions of the available data in
three sets, termed training, validation, and test. Then, the validation set is
used to tune the parameters of the learning algorithm (learning rate, when
to stop learning, etc.).
A hidden difficulty arises when we have several samples obtained from
the same subjects collected at different times (see reference [23] for an ex-
ample how to handle this kind of situation correctly). Then, all the samples
obtained from the same subject need to be in either training or test set. It is
inappropriate that some samples obtained from, say, J (two-years ago) are in
the training set while others obtained (a year ago) from J are in the test set.
In other words, training and test sets must be independent. If the two sets
are not independent, then the estimates of the test error will be positively
biased and the magnitude of this bias can be surprisingly large.
4.2. Cross-validation
Cross-validation is a resampling procedure to estimate the test error. It
is a generalization of the holdout method. In k-fold cross-validation (CV),
the training set (X, Y ) is split into k smaller sets (X1, Y1), . . . , (Xk, Yk) and
the following procedure is followed for each of the k folds (see Figure 3):
1. A machine learning model is trained using all the except the ith fold
folds as training data;
2. the resulting model is tested on ith fold (Xi, Yi).
The performance measure of k-fold CV is then the average of the val-
ues computed in the loop. In textbooks that are several decades old, k-
fold CV has been viewed as computationally expensive, and therefore, the
holdout method (see Section 4.1) has been suggested for relatively modest
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Figure 3: 5-fold cross-validation. In each fold, the samples marked by blue color are
used as training data, and the samples marked by yellow are the test samples. Each fold
produces an error estimate Eˆi, i = 1, . . . , 5, which are then averaged to obtain the total
error estimate.
sample sizes. However, computers are now much faster than in the eighties
or nineties, and k-fold CV is not likely to be computationally prohibitive
in current health and wellness applications. Likewise, there exists a wrong
perception that holdout would be (theoretically) preferable to CV, but this
is not true. Further, the distinction between cross-validation and holdout is
not the same as the distinction between internal and external validation. In
particular, the holdout method is not a surrogate for having an independent
test set.
The parameter k is usually selected as 5 or 10 according to suggestions
given by [24] 9. However, in many cases, there might be a natural division
of the data into k-folds, for example, the data may have been collected in k
different medical centers, and then that natural division should be preferred.
A special case, useful when the sample size is small, is leave-one-out CV
(LOOCV), where each sample (or subject) forms its own fold, and thus k
is equal to the number of data samples. Finally, remarks made about the
independence of training and test sets in Section 4.1 hold also for k-fold CV
– each fold should be independent.
Repeated CV fixes the inherent randomness of the selection of the folds
by re-running a k-fold CV multiple times. There are different opinions if
this is useful or not, and in the opinion of the authors, rarely more than ten
repeats are necessary. Note that different repeats of CV are not independent,
so, for example, the variance of error estimates resulting from different CV
9Kohavi [24] recommends to use k = 10 as 5-folds led to pessimistic bias in some of the
reported experiments
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runs (note the difference between runs and folds of a single run) is a useless
quantity concerning the variance of the generalization error [22].
In stratified CV, the folds are stratified so that they contain approximately
the same proportions of labels as the original data. For example, if 10 % of
the training data belongs to the class 1 and 90 % of the training data belong
to the class 2, then each fold should also have approximately this 10/90
division. The stratification is typically highly recommended [24].
4.3. Cross-validation and holdout caveats
CV and holdout only yield meaningful results if they are used correctly.
Common pitfalls include:
• Using the test labels (i.e., correct classes of the test set) in feature
selection and/or extraction. Selecting features for the classification
using the whole data (i.e., not just training set), leads to optimistically
biased classifier performance estimates as demonstrated in, e.g., [25].
However, there exist also more subtle variations of the same issue.
For example, preprocessing the data with principal component analysis
(PCA) based on all the subjects of the healthy class commits the same
mistake as it (inadvertently) uses the labels to select the data for PCA.
More generally, if CV is used to simultaneously to optimize the model
parameters and estimate the error (within the same CV), the error
estimates will be optimistically biased and a procedure called nested
CV is necessary with parameter tuning [26, 27] – we will return to this
issue in Section 4.3.3.
• Failing to recognize that CV-based error estimates have large variance
especially when the number of samples is low. In this case, the classifier
may appear very good (or bad) just because of chance. This issue,
discovered over 40 years ago [28], has received a reasonable amount of
attention recently [29, 27, 30, 31, 32, 33], however, its effects are still
often underestimated.
• Selecting folds in a way that the training and test sets are not indepen-
dent, for example, when more than one sample exists from the same
subject as we discussed in Section 4.1.
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4.3.1. Fully independent test sets versus cross-validation test sets: is there a
difference?
Many have voiced (e.g., [15]) the requirement for independent test sets for
the evaluation of machine learning algorithms in health and life science ap-
plications. Especially, if a clinical applicability of a trained machine learning
model for a particular task needs to be evaluated, this is absolutely manda-
tory. However, we stress that the test set needs 1) to be truly independent
(preferably not existing at the training time, see, e.g., a recent competition
on Alzheimer’s disease prediction for a good example [34, 35]), and 2) needs
to model the actual task as well as possible (i.e, collecting the test set at a
hospital A when the actual method is to be used at a different hospital B
may not be optimal).
Breaking an already existing dataset into training and test sets as in the
holdout method is rarely a good idea if the dataset is not large (in terms of
the number of subjects) but it is better to use the cross-validation. What
”large” means is dependent on the task at hand 10, but to give a general
guideline: 1) datasets of over 10,000 subjects can be divided into train and
test sets, 2) datasets of 1000 to 10000 subjects, this depends on the case
at the hand, 3) datasets under 1000 subjects: cross-validation is typically
better. Also, if the data has been collected at several hospitals, it is relevant
to perform leave-one-hospital out cross-validation and report the errors in
all the hospitals, instead of selecting some hospitals as training and some as
testing sets.
It is good to keep in mind that the cross-validation approximates the
performance of the classifier trained with all the available data. The classi-
fiers derived from using different folds as the training set will differ. Thus,
if a specific classifier needs to be evaluated, there is no alternative to the
collection of a large test set [21].
4.3.2. Cross-validation vs. holdout
Voicing the requirement for independent test sets for the evaluation of ma-
chine learning algorithms in health and life science applications has brought
with it the confusion that the hold-out would be preferable to the CV-based
10The question is extremely delicate and parallels the question how much data is needed
for machine learning solution for a particular problem. The answer to both questions
depends both on the complexity of the task and on the complexity of the selected ML
method.
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error estimation. However, in the absence of a truly separate test set, CV
leads always to better estimates of the predictive accuracy than the holdout
as is demonstrated by a simulation in Figure 4, where CV-based error es-
timates have much smaller mean absolute errors than hold-out based ones.
This is because, in CV, the results of multiple runs of model-testing (with mu-
tually independent test sets) are averaged together while the holdout method
involves a single run (a single test set). The holdout method should be used
with caution as the estimate of predictive accuracy tends to be less stable
than with CV. In the simulation depicted in Figure 4, both CV and holdout
based error estimates are almost unbiased.
Figure 4: CV versus holdout with simulated data. The plot shows the mean absolute error
in the classification accuracy estimation using CV and holdout with respect to a large,
external test set consisting of one million samples. The plot shows that the classification
accuracy estimate by 5-fold CV is always over two times better than the classification
accuracy estimate using holdout with 20 % of training data in the test set. The number of
features was varied (d = 1, 3, 5, 9), but the classification task was tuned in a way that the
Bayes error was always 5 %. When the task was tuned this way, the number of features
had very little effect on the accuracy of the estimated error. The classes were assumed to
be Gaussian distributed with equal diagonal covariances and the two classes were equally
probable. The classifier was the GNB introduced in Section 2. We trained GNBs with
1000 different training sets of the specific size to produce the figure. The code reproducing
this experiment can be retrieved at https://github.com/jussitohka/ML_evaluation_
tutorial
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4.3.3. Selecting classifier parameters in holdout or cross-validation
Modern ML algorithms come often with various hyper-parameters to tune
(for example, the parameter C in support vector machines, mtry parameter
in Random Forest, when to stop training in neural networks). If using hold-
out, the recommendation is to divide the data into three non-overlapping
sets: 1) a training set to train the classifiers with various hyperparameters,
2) a validation set to decide which of the trained classifiers to use, and 3) a
test set to the test the accuracy of the selected classifier. As we have already
stated, omitting the test set, and estimating the accuracy based on the best
result on the validation set can lead to severely positively biased accuracy
estimates.
Likewise, when CV is used simultaneously for selection of the best set
of hyperparameters and for error estimation, a nested CV is required [26].
This again as model selection without nested CV uses the same data to tune
model parameters and evaluate model performance leading to upward biased
performance estimates demonstrated in several works [26, 25]. There exist
several variants, but the basic idea, as the name indicates, is to perform a
CV loop inside a CV loop. First, the whole data set is divided into k folds,
and one at the time is used to test the model trained with the remaining
k−1 folds as in above with the ordinary CV. However, a CV is performed in
each of k−1 training sets to select the best hyperparameters, which are then
applied to train a model with on the (outer) training sets. A pseudo-code
for nested CV is presented in [25].
The high variance of the CV (and other non-parametric error estimators)
hinders also the selection of hyperparameters for classification algorithms
[27, 31] and, as a result, one should not be overly confident about the selected
hyperparameters in small-sample settings.
4.4. Hypothesis testing
In order to to compare learning algorithms, experimental results reported
in the machine learning literature often use statistical tests of significance.
These tests answer, in a principled manner, the question if one machine
learning algorithm is better than another on a particular learning task. How-
ever, statistically testing the significance is not completely straight-forward
in machine learning scenarios. An early work by Dietterich demonstrated
the drawbacks of some commonly used tests and suggested 5x2 CV test and
McNemar test to compare the learning algorithms [36]. Nadeau and Bengio
proposed corrected resampled t-test, which is the one that we recommended
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Figure 5: The bootstrap. m samples of the original data are produced by sampling with
repetition allowing a training example to enter to the sample more than once. Out-of-bag
samples, labeled in yellow in the figure, are then used to estimate the test error.
for comparing two learning algorithms [22]. This test is advantageous be-
cause it takes into account variability due to the choice of training set. A
corrected repeated k-fold CV test is a version of this test that is particularly
easy to implement [37].
4.5. Alternatives to cross-validation
There are several (non-parametric and parametric) alternatives to CV [38,
39, 40]. We will explain in more detail one of these, bootstrapping [41], as it
is convenient in learning algorithms that utilize re-sampling (e.g., bagging in
Random Forests [42]). In these algorithms, bootstrap (or variations thereof)
error estimates are a side-product of the classifier training [43].
4.5.1. Bootstrapping
In bootstrapping, depicted in Figure 5, the central idea is to select random
bootstrap samples from the dataset. Typically, these bootstrap samples are
of the same size as the original sample, but sampled allowing repetition.
(For example, in the first bootstrap sample of Figure 5 (B1), the sample
X5 is selected 5 times.) Then, the classifier is trained with the bootstrap
sample and evaluated with the samples that were not selected as part of the
bootstrap sample. These samples, labeled with yellow color in Figure 5, are
called out-of-bag samples. This process is repeated m times. A commonly
used variant is .632 bootstrap estimate [40], which, however, can be upward
biased especially for low accuracies [24].
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4.6. Practical considerations
4.6.1. Dealing with small sample sizes
Machine learning experts often get the question of what is the minimum
sample size to design a machine learning algorithm. This is a tricky question
as it depends on the application and what is the required performance. Also,
for specific applications such as image segmentation, a very small number
of images may be sufficient because every pixel is a sample. Instead, image
classification may require many more images as now only each subject is a
sample. However, the training sample must represent the population of all
possible subjects well enough.
If the available training set size is small in terms of the number of sub-
jects, it is essential to use simple learning algorithms. Note that the term
’simplicity’ refers to the number of parameters the algorithm has to learn.
For example, a GNB classifier learns 2d+1 parameters, where d is the number
of features. Nearest-neighbor classifier, albeit simple to implement, leads to
much more complicated decision regions and more parameters to be learned
[44]. GNB is typically a good choice if the number of samples is small.
Also, as we have emphasized, it is a good idea to take CV-based and, in
particular, holdout-based error estimates critically if the number of samples
is small. As shown in Figure 4 the mean absolute error of the holdout error-
estimate is larger than the Bayes error when the number of samples per
class is 25 and, for the majority of iterations, the holdout reports zero errors
(while the Bayes error-rate is 5%). To combat the small sample size problem,
there are parametric error estimators that may succeed better than their
non-parametric counterparts in small-sample scenarios [39]. Note that the
effective sample size is the number of training data in the smallest class, i.e.,
if we have 1000 examples of one class and 3 of another, the trained classifier
is not likely to be accurate.
4.6.2. Dealing with highly imbalanced class divisions
If faced with the situation with highly imbalanced class divisions, few
considerations are necessary. First, as outlined in Section 3, it is essential to
use an error measure that is appropriate for the problem. Second, if select-
ing hyperparameters of the algorithm, it is essential to use the same error
measure to select the parameter values. Third, the use of stratification in
the CV is absolutely necessary. Care should be taken when using oversam-
pling techniques, such as SMOTE [45], as these do not actually increase the
number of training data.
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4.6.3. Computing ROCs and AUCs using CV
There are several choices when combining the AUCs from the different
test partitions. Two of the simplest are [46]:
• Pooling. The frequencies of true positives and false positives are aver-
aged. In this way one average, or group ROC curve is produced from
the pooled estimates of each point on the curve.
• Averaging. AUC is calculated for each test partition and these AUCs
are then averaged.
More techniques for combining ROCs from several test partitions are intro-
duced in [47].
5. Conclusions
The increasing efforts in research and development using data-driven ap-
proaches have both positive and negative effects. On the positive side, new
applications and solutions are delivered to problems that were ten years ago
still considered prohibitively difficult to solve. Think, e.g., of image recog-
nition, speech recognition, natural language processing in general, and the
highly successful advances in medical technology, especially in the image
analysis field and assisted diagnostics. On the negative side, there is a hype
situation in which there are unrealistic expectations with regard to techniques
such as AI and machine learning. High expectations are set both by end-
users or customers as well as in the scientific community itself. This leads
to a situation where a thorough objective assessment of the performance is a
task that is under pressure. As we have seen, proper performance assessment
is not trivial (requires an understanding of the problem and data), and often
costly (data needs to be reserved) and costs time. It is often less exciting
than the development/training work itself and has the unfortunate property
that often the performance estimations after objective validation are less than
the ’highly promising’ results that were obtained in the early development
phase. Thus, meaning that enthusiasm from colleagues, potential customers,
investors, and end-users might decrease as a consequence of ’proper’ testing.
All in all, there is pressure to deliver fast and publish (positive!) results as
soon as possible.
The tendency to publish only results that ’improve upon the state-of-the-
art (SotA)’ is an increasing problem. This problem leads to situations where
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algorithms and parameter sets are tuned and re-tuned almost indefinitely
towards an as good as possible performance; ’SotA-hacking’. This becomes
highly problematic when the overall dataset is fixed, as is the case in publicly
available databases or datasets available for pattern recognition competitions.
No matter whether an appropriate CV scheme is used and an ’independent’
test set is provided, the fact remains that an enormous amount of effort is
dedicated to finding the optimal solution to one specific data set. There is
insufficient information about how the algorithm behaves on other data in
real-life. This is sometimes referred to as ’meta-training’, as researchers are
getting trained themselves and their environment to optimise their work for
a specific data-set.
The overall problem is wide and ultimately originates from inappropriate
experimental design and hypothesis testing procedures, including so-called
Hypothesizing After the Results are Known (aka HARKing) practices. The
interested reader can find more information in [48]
This paper aimed to give practical information about how to assess the
performance of machine learning approaches, giving special attention to biomed-
ical applications. It is meant as a pragmatic set of guidelines and collection of
practical experiences gained in the field over several decades of research. We
hope it allows the interested reader to take a critical and objective look on the
subject and understand the main issues underlying performance assessment.
Finally, it is worthwhile to re-emphasise that good performance is only
one of the items in the list of requirements towards successful uptake of
machine learning algorithms in practice: usability, seamless integration into
existing processes and infrastructures, and explainability are all components
that are of similar importance. They have their own metrics.
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